Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Punchcut Appoints Akshat Srivastava Director of Design Engineering
-
Legrand Acquires Avtron Power Solutions, a Global Provider of Load Banks & Power Quality Solutions
-
IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
-
Trained Therapeutix Demonstrates RIDE-001 Trains Myeloid Cells for Anti-Tumor Immune Response in Preclinical Data Presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
-
Nurix Therapeutics Presents New Translational Data from First-in-Human Clinical Trial of Oral CBL-B Inhibitor NX-1607 Demonstrating Immune Activation and Tumor Microenvironment Remodeling
-
Gold Prices Continue to Fluctuate at High Levels, Blue Hat's Gold Assets Deliver Significant Returns
-
BioAtla’s Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas
-
Wrap and LETAC Lead Policy Development for Human Centered Non-Lethal Integration of Humanoid Robotics in Public Safety
-
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
-
Precision Optics Announces Product Development Agreement to Deliver Next-Generation Augmented Reality Sub-Systems for Fighter Pilots
-
Nouscom Presents New Positive Phase 1/2b data of NOUS-209 at SITC 2025, Supporting Plans to Initiate Registration-Enabling Study for Cancer Interception in Lynch Syndrome Carriers
-
Creative Realities Closes Acquisition of Cineplex Digital Media
-
Trump Media Reports Third Quarter 2025 Results
-
H/Advisors Abernathy Named Private Equity Wire’s U.S. PR & Communications Firm of the Year in 2025 for Second Consecutive Year
-
Flare Therapeutics Presents Correlative Biomarker Analysis from the FX-909 Phase 1A Clinical Study at SITC 2025 40th Anniversary Annual Meeting
-
Wearable Devices Expands into Asia’s Tech Powerhouse: Secures Exclusive Distribution Agreement in South Korea
-
RFN's SX-E60: A New Era of Control in Electric Off-Roading Explored at EICMA Roundtable
-
Draganfly to Host Shareholder Update Call on November 12, 2025
-
Fullmark Energy Announces Completion of Redwood Projects Portfolio with Commercial Operations of 65MW San Jacinto Energy Storage Project
-
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
-
Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
-
MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025
-
Legrand Acquires Avtron Power Solutions, a Global Provider of Load Banks & Power Quality Solutions
-
ETC’s Commercial/Industrial Unit Awarded Contracts Totaling $9.1 Million
-
Round Table Pizza Brings Legendary Flavor to Austin Area
-
CTS Corporation Declares a Dividend and Share Repurchase Program
-
Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC
-
NextNRG Reports Preliminary October 2025 Revenue Growth of 196% Year-Over-Year
-
Gold Prices Continue to Fluctuate at High Levels, Blue Hat's Gold Assets Deliver Significant Returns
-
EQ Appoints Nicholas Nichols as Executive Vice President of Mutual Funds
-
T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy at the Society for Immunotherapy of Cancer (SITC) Annual Me
-
Tizona Therapeutics Presents Clinical Translational Evidence of Dual Innate and Adaptive Immune Activation with TTX-080, a First-in-Class HLA-G Antagonist, in Patients with Advanced Solid Tumors at SI
-
Financial calendar 2026
-
Nokia Corporation - Managers' transactions (Heard)
-
Sampo plc: Managers’ Transactions (Witschard)
-
Sampo plc: Managers’ Transactions (Stange)
-
Sampo plc: Managers’ Transactions (Rauramo)
-
Sampo plc: Managers’ Transactions (Langan)
-
Changes in Nokia Corporation's own shares
-
Sampo plc: Managers’ Transactions (Mella)
-
Sampo plc: Managers’ Transactions (Murto)
-
LITGRID AB 2025 9 months performance results
-
Sampo plc: Managers’ Transactions (Mäkinen)
-
ANNOUNCEMENT OF INTENTION TO MAKE A VOLUNTARY TAKEOVER BID TO ACQUIRE THE SHARES OF AKTSIASELTS EKSPRESS GRUPP
-
Nouscom Presents New Positive Phase 1/2b data of NOUS-209 at SITC 2025, Supporting Plans to Initiate Registration-Enabling Study for Cancer Interception in Lynch Syndrome Carriers
-
American Battery Technology Company Announces First Quarter Fiscal 2026 Financial Results
-
Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide
-
Ipsen to present two late-breaking sessions at AASLD on new PBC data supporting IQIRVO®’s long-term efficacy, safety and mechanistic insights in fatigue
-
Today's Marketplace discusses state of M&A with Creighton University’s Tirimba Obonyo and Moelis’s Mark Henkels
-
Today's Marketplace discusses state of M&A with Creighton University’s Tirimba Obonyo and Moelis’s Mark Henkels
